摘要
目的:研究雄黄微生物提取液(RBS)诱导K562/ADM细胞凋亡的作用,并探讨其对P-糖蛋白(P-gp)和多药耐药基因(MDRI)表达的影响。方法:采用"微生物浸出"法制备RBS,并以H3AsO3作为阳性对照,AnnexinV-PI双染法检测细胞凋亡;流式细胞仪检测细胞P-gp表达率;逆转录聚合酶链技术(RT-PCR)检测细胞MDRI mRNA表达水平。结果:RBS可诱导多药耐药白血病细胞发生典型凋亡,抑制P-gp的表达,下调MDRImRNA表达水平。在含砷量相同的条件下,RBS诱导效应明显强于H3AsO3。结论:诱导细胞凋亡、下调P-gp/MDRI蛋白的表达,可能是雄黄逆转白血病耐药的重要分子机制。
AIM: To investigate the role of apoptosis in K562/ADM cells induced by realgar bioleaching solution (RBS), and illustrate the possible molecular mechanism. METHODS: RBS was prepared by a new method of bioleaching with bacteria. The cell apoptosis was determined by annexin V/PI double staining. The expressions of MDRI mRNA and P-gp were detected by RT-PCR and flow cytometry, respectively. The parallel experiments with arsenic acid (H3 As03 ) were conducted for comparison. RESULTS: RBS inhibited K562/ ADM cells growth effectively, and the apoptosis rate of the cells by AnnexinV/PI staining was obviously increased, the expressions of MDRI mRNA and P-gp were significantly down-regulated. With the same concentration of As, the inducing effect of RBS was more stronger than H3 AsO3. CONCLUSION: RBS induces the apoptosis in K562/ADM cells. The down-regulation of MDRI/P-gp expression may be the important molecular mechanisms in reversing the multi-drug resistance leukemia cells.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2009年第8期855-860,共6页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
甘肃省科技攻关项目(2GS064-A43-019-02)
福建省自然科学基金项目(2008J0102)
泉州市基金项目(2008Z21)